| Code | 6535E | ||||||||||
| MA number | 31/0123/24-S | ||||||||||
| Product Form: | tbl flm 90x10 mg/20 mg (blis.Al/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Olpha AS, Latvia | ||||||||||
| Therapeutic Class: | 31 - HYPOLIPIDAEMICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 30 | ||||||||||
| Container: | blister Al/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 15.06.2024 |
| Validity: | 15.06.2029 |
| PIL: |
PIL_Ezetimibe-Atorvastatin Olpha_02.2025.pdf
|
| SPC: |
SPC_Ezetimibe-Atorvastatin Olpha_02.2025.pdf
|
| Safety feature | Yes |
| Data update: | 11.02.2025 |
